Literature DB >> 20493693

Prenylcoumarin with Rev-export inhibitory activity from Cnidii Monnieris Fructus.

Satoru Tamura1, Toshiaki Fujitani, Masafumi Kaneko, Nobutoshi Murakami.   

Abstract

By use of the fission yeast expressing the model fusion protein comprised of GST, SV40 T antigen NLS, GFP, and Rev-NES in the bioassay, the prenylcoumarin osthol (1) was disclosed as the new Rev-export inhibitor from the MeOH extract of Cnidii Monnieris Fructus. Furthermore, 1 was also found to inhibit export the genuine Rev in HeLa cells by indirect fluorescent antibody technique. By the competitive experiment using the biotinylated probe 3, osthol (1) was revealed to inhibit nuclear export of Rev through a NES non-antagonistic mode. Structure-activity relationship analysis of several analogs of 1 clarified that both prenyl side chain and double bond adjacent to the lactone carbonyl residue play an important role in the Rev-export inhibitory potency of 1. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493693     DOI: 10.1016/j.bmcl.2010.04.081

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  CRM1 Inhibitors for Antiviral Therapy.

Authors:  Cynthia Mathew; Reena Ghildyal
Journal:  Front Microbiol       Date:  2017-06-28       Impact factor: 5.640

Review 2.  Phytochemistry, Ethnopharmacology, Pharmacokinetics and Toxicology of Cnidium monnieri (L.) Cusson.

Authors:  Yue Sun; Angela Wei Hong Yang; George Binh Lenon
Journal:  Int J Mol Sci       Date:  2020-02-03       Impact factor: 5.923

Review 3.  Osthole: A Review on Its Bioactivities, Pharmacological Properties, and Potential as Alternative Medicine.

Authors:  Zhong-Rong Zhang; Wing Nang Leung; Ho Yee Cheung; Chun Wai Chan
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-13       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.